Segmentation Artificial Intelligence (AI) For Pathology Slides Market Report 2026

Segmentation Artificial Intelligence (AI) For Pathology Slides Market Overview

• Segmentation Artificial Intelligence (AI) For Pathology Slides market size has reached to $1.02 billion in 2025 • Expected to grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 23.9% • Growth Driver: Rising Prevalence Of Cancer Fueling The Growth Of The Market Due To The Need For Automated, Precise, And Efficient Tumor Identification • Market Trend: Advancing Automated Tissue Segmentation To Enhance Diagnostic Accuracy And Streamline Pathology Workflows • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Segmentation Artificial Intelligence (AI) For Pathology Slides Market?

Segmentation AI for pathology slides refers to artificial intelligence models designed to automatically identify, outline, and classify specific structures, cells, or regions within digitized pathology slides. These systems help pathologists by highlighting tumors, tissues, biomarkers, and anomalies with high precision and consistency. They improve diagnostic accuracy, reduce analysis time, and support advanced research and computational pathology workflows. The main components of segmentation artificial intelligence solutions for pathology slides are software, hardware, and services. Software consists of artificial intelligence algorithms that perform automated tissue segmentation and pattern recognition on digitized pathology slides to support diagnostic accuracy and workflow efficiency. These solutions are based on deep learning-based segmentation, convolutional neural network models, multi-class tissue classification, and hybrid artificial intelligence models, deployed through cloud-based platforms, on-premise systems, and hybrid deployments, used in applications such as cancer diagnosis, disease detection, research, drug development, and others, among end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Segmentation Artificial Intelligence (AI) For Pathology Slides Market Growth Forecast?

The segmentation artificial intelligence (AI) for pathology slides market size is expected to see exponential growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to growing integration of deep learning in pathology workflows, increasing adoption of automated segmentation tools, rising demand for real-time slide analysis, expanding investment in AI-powered diagnostic platforms, growing emphasis on precision medicine and personalized treatment. Major trends in the forecast period include technology advancements in neural network-based segmentation, innovations in AI-driven pattern recognition, developments in high-resolution digital slide processing, research and development in multi-modal pathology analysis, advancements in cloud-based AI pathology solutions.

Global Segmentation Artificial Intelligence (AI) For Pathology Slides Market Segmentation

1) By Component: Software, Hardware, Services 2) By Technology: Deep Learning-Based Segmentation, Convolutional Neural Network (CNN) Models, Multi-Class Tissue Classification, Hybrid AI Models (Rule-Based + ML) 3) By Deployment Mode: Cloud-Based AI Platforms, On-Premise AI Systems, Hybrid AI Deployment 4) By Application: Cancer Diagnosis, Disease Detection, Research, Drug Development, Other Applications 5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Others End Users Subsegments: 1) By Software: Image Processing Algorithms, Deep Learning Models, Annotation Tools, Workflow Integration Platforms, Model Training Frameworks 2) By Hardware: High-Performance Computing Systems, Graphics Processing Units, Dedicated Inference Devices, Data Storage Servers, Edge Processing Units 3) By Services: Deployment Services, Integration Services, Training And Support Services, Validation And Testing Services, Maintenance And Upgradation Services

What Is The Driver Of The Segmentation Artificial Intelligence (AI) For Pathology Slides Market?

The rising prevalence of cancer is expected to propel the growth of the segmentation artificial intelligence (AI) for pathology slides market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Segmentation artificial intelligence (AI) for pathology slides helps manage cancer by automatically identifying and delineating tumor regions within digital tissue images. It improves diagnostic precision and efficiency, enabling more accurate treatment planning and personalized therapeutic strategies. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed cancer at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the segmentation artificial intelligence (AI) for pathology slides industry.

Key Players In The Global Segmentation Artificial Intelligence (AI) For Pathology Slides Market

Major companies operating in the segmentation artificial intelligence (AI) for pathology slides market are PathAI Inc., Lunit Inc., Deciphex Ltd., AetherAI Co. Ltd., Proscia Inc., Aignostics GmbH, Visiopharm A/S, Indica Labs Inc., PathPresenter Ltd., Gestalt Diagnostics Inc., Ibex Medical Analytics Ltd., HistoWiz Inc., Deep Bio Inc., Mindpeak GmbH, Nucleai Ltd., Vuno Inc., Aiosyn B.V., Aiforia Technologies Oyj, Stratipath Medical Ltd., AIVIS Inc.

Global Segmentation Artificial Intelligence (AI) For Pathology Slides Market Trends and Insights

Major companies operating in the segmentation AI for pathology slides market are focusing on developing advanced tissue segmentation solutions, such as AI-powered whole slide image analysis platforms, to improve diagnostic precision, reduce manual annotation, and accelerate pathology workflows. AI-powered whole slide image analysis platforms refer to software systems that automatically identify and delineate tissue regions, cells, and anomalies within digital pathology slides, enabling pathologists to perform accurate and reproducible assessments efficiently. For instance, in June 2024, HistoWiz Inc., a US-based digital pathology services company, launched PathologyMap 2.0, an integrated AI-powered whole slide image analysis platform that performs automated tissue segmentation, provides one-click quality control of whole slide images, and supports flexible metadata integration across slide repositories. These features enable rapid tissue identification, streamline slide review, and ensure consistent segmentation outputs for downstream diagnostic and research applications. By combining high-throughput AI segmentation, built-in quality checks, and workflow integration, PathologyMap 2.0 represents a significant advancement in digital pathology, improving both efficiency and diagnostic confidence.

What Are Latest Mergers And Acquisitions In The Segmentation Artificial Intelligence (AI) For Pathology Slides Market?

In August 2025, Tempus AI Inc., a US-based technology company, acquired Paige.AI Inc. for approximately $81.2?million. With this acquisition, Tempus AI aims to enhance its AI-powered digital pathology capabilities by integrating Paige’s advanced algorithms for tissue and cell segmentation, expanding its clinically annotated pathology dataset, and accelerating the development of AI models for cancer detection and diagnostic workflows, thereby strengthening its position in the global digital pathology market. Paige.AI Inc. is a US-based provider of advanced AI algorithms and models for digital pathology that operate on digitized whole?slide images (WSIs).

What Defines the Segmentation Artificial Intelligence (AI) For Pathology Slides Market?

The segmentation AI for pathology slides market consists of revenues earned by entities by providing services such as image preprocessing, automated annotation, quantitative pathology analysis, workflow automation, and diagnostic decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The Segmentation AI for Pathology Slides market includes sales of cell segmentation, nuclei segmentation, tissue region segmentation, tumor boundary segmentation, and artifact detection segmentation. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What Is The Driver Of The Segmentation Artificial Intelligence (AI) For Pathology Slides Market?

The rising prevalence of cancer is expected to propel the growth of the segmentation artificial intelligence (AI) for pathology slides market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Segmentation artificial intelligence (AI) for pathology slides helps manage cancer by automatically identifying and delineating tumor regions within digital tissue images. It improves diagnostic precision and efficiency, enabling more accurate treatment planning and personalized therapeutic strategies. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed cancer at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the segmentation artificial intelligence (AI) for pathology slides industry.

Regional Insights

North America was the largest region in the segmentation artificial intelligence (AI) for pathology slides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Segmentation Artificial Intelligence (AI) For Pathology Slides Market Report 2026?

The segmentation artificial intelligence (ai) for pathology slides market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the segmentation artificial intelligence (ai) for pathology slides industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.